Reports for TEVA-IRBESARTAN HCTZ
Brand name
TEVA-IRBESARTAN HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02330520 |
Ingredients
IRBESARTAN HYDROCHLOROTHIAZIDE |
Ingredient Strength
300 MG 12.5 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2018-03-13 | 2018-05-30 | 42582 |
TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
TEVA-IRBESARTAN HCTZ | 100 | Resolved | 2024-04-11 | 2024-06-29 | 224895 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-IRBESARTAN HCTZ | 100 | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
Showing 1 to 1 of 1